MedPath

MOMETACURE

These highlights do not include all the information needed to use MOMETASONE FUROATE CREAM safely and effectively. See full prescribing information for MOMETASONE FUROATE CREAM. MOMETASONE FUROATE cream, for topical use Initial U.S. Approval: 1987

Approved
Approval ID

1f877960-26a0-4bb7-a013-3a49af872c0e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 8, 2023

Manufacturers
FDA

FORREAL PHARMACEUTICALS LLC

DUNS: 118029197

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

mometasone furoate, Dimethicone

PRODUCT DETAILS

NDC Product Code81877-520
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationTOPICAL
Effective DateNovember 8, 2023
Generic Namemometasone furoate, Dimethicone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MOMETACURE - FDA Drug Approval Details